Has Michael Bianco received payments from drug or device companies?

Yes. Drug and device makers reported $5,533 in general payments to Michael Bianco across 323 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Bianco did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Bianco come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Bianco

Internal Medicine · Wadsworth, OHNPI 1740212885

Payments from drug & device makers

$5,533in general payments, 2019–2025

Across 323 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$463
AbbVie$431
Amgen$357
Cook Medical LLC$340
Lilly USA, LLC$325
plus $3K from 29 others

What the payments were for

Food & beverage$5,515100%
Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	57	$1,023
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	26	$463
AbbVie(2 entities)	30	$431
Amgen	24	$357
Cook Medical LLC	4	$340
Lilly USA, LLC	27	$325
AstraZeneca	20	$320
GSK	16	$295
Boehringer Ingelheim	13	$275
Astellas Pharma US Inc	10	$174
Biohaven Pharmaceuticals, Inc.	15	$154
Amarin Pharma, Inc.	10	$148
Takeda Pharmaceuticals U.S.A., Inc.	7	$143
Integra Lifesciences Corporation	1	$143
Novartis	8	$109
Pfizer	8	$104
Johnson & Johnson	6	$79
Ironshore Pharmaceuticals Inc.	4	$68
Clarus Therapeutics Inc.	4	$60
Endo Pharmaceuticals Inc.	4	$59
Genentech USA, Inc.	3	$56
Merck	4	$53
Sunovion Pharmaceuticals Inc.	3	$38
Bayer	2	$37
Daiichi Sankyo Inc.	2	$35
Sanofi-aventis U.S. LLC	2	$33
Eisai Inc.	2	$32
Jazz Pharmaceuticals Inc.	2	$32
E.r. Squibb & Sons, L.L.C.	2	$31
Kowa Pharmaceuticals America, Inc.	2	$24
Amneal Pharmaceuticals LLC	1	$23
Biogen	1	$20
Avanir Pharmaceuticals, Inc.	1	$19
Mannkind Corporation	1	$18
UCB, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,533 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio →

Other internal medicine in Wadsworth

Antoinette PragalosCincinnati$27.8M
Steven FolkerthBeavercreek$9.1M
Charles EgerCincinnati$8.7M
Vadim KoshkinCleveland$6.1M
Nizar DaboulMaumee$4.7M
Douglas LoganCincinnati$4.7M
Seref BornovaliLoveland$4.4M
Yevgeniy BukhmanCanton$3.7M
Leela VrishabhendraCincinnati$3.4M
Narinder SainiSpringfield$3.2M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →